What's happening
This bill prohibits insurance companies in New York from charging fees or co-pays for one follow-up visit to get an opioid prescription refill after an initial short-term prescription.
Why it matters
Reduces barriers for patients needing legitimate opioid refills. By eliminating out-of-pocket costs for one follow-up visit after an initial short-term opioid prescription, the bill helps ensure that patients with acute pain don’t skip medically necessary care due to financial concerns.
Supports safer opioid prescribing practices. The bill aligns with guidelines that encourage short initial opioid prescriptions and require reassessment before extending use. Removing the financial penalty for a follow-up visit may encourage doctors and patients to follow safer, stepwise prescribing protocols.
Limits the scope to prevent abuse. The prohibition on fees or co-pays applies only to one follow-up visit or refill, preventing unlimited free visits and reducing potential for misuse while still addressing a key need for pain patients.
Could impact insurance and healthcare costs. By mandating coverage for certain follow-up visits without patient cost-sharing, the bill may have financial implications for insurers, potentially shifting some costs from patients to insurance pools.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
No Copays for Opioid Refills
Plain English, a few words. Used as the page title.
Sponsors
3 Co-sponsors
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
End Opioid Refill Co-Pays
In Senate Committee · Insurance · Sponsor Robert Ortt
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
3903
2021-2022 Regular Sessions
IN ASSEMBLY
January 28, 2021
Introduced by M. of A. DeSTEFANO, SALKA, REILLY, SAYEGH -- read once and referred to the Committee on Insurance
AN ACT to amend the insurance law, in relation to prohibiting insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 36 to read as follows:
(36) Every policy which provides coverage for opioid drug prescriptions shall not impose any fee, co-payment, co-insurance, deductible or other condition on any insured who requires a follow up appointment to receive an additional opioid drug prescription or a refill of an opioid drug prescription after an initial prescription for such opioid drug prescription which was written for a period of seven days or less. Such prohibition on any fee, co-payment, co-insurance, deductible or other condition is limited to one visit or one refill after the initial appointment or prescription. Upon any subsequent consultation for the same pain, the practitioner may issue, in accordance with this subsection, any appropriate renewal, refill, or new prescription for the opioid or any other drug.
§ 2. This act shall take effect on the ninetieth day after it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD07487-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.